10 Things Worth Pay...
Health Care: Drugs
ACADIA Pharmaceuticals Inc. (ACAD: NASDAQ)
$1.33 0.02 | 1.53%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 2.07M | 42.14M | 6.40M | 1.59M |
| Cost of Sales | -390.00K | -607.00K | -1.11M | -1.95M |
| Gross Operating Profit | 2.46M | 42.74M | 7.51M | 3.54M |
| Selling, General, and Administrative Expenses | 7.61M | 6.46M | 10.28M | 11.82M |
| Research & Development | 17.31M | 20.58M | 41.58M | 56.75M |
| Operating Income before D & A (EBITDA) | -22.46M | 15.70M | -44.36M | -65.02M |
| Depreciation & Amortization | 390.00K | 607.00K | 1.11M | 1.95M |
| Interest Income | 87.00K | 45.00K | 409.00K | 2.92M |
| Other Income - Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -22.76M | 15.14M | -45.06M | -64.06M |
| Interest Expense | 0.00 | 0.00 | 86.00K | 181.00K |
| Pre-Tax Income | -22.76M | 15.14M | -45.14M | -64.24M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -22.76M | 15.14M | -45.14M | -64.24M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -22.76M | 15.14M | -45.14M | -64.24M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -22.76M | 15.14M | -45.14M | -64.24M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-22.76M | 15.14M | -45.14M | -64.24M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -22.76M | 15.14M | -45.14M | -64.24M |
| Basic EPS from Continuing Ops. | -0.44 | 0.39 | -1.20 | -1.73 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.44 | 0.39 | -1.20 | -1.73 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.44 | 0.39 | -1.20 | -1.73 |
| Basic Normalized Net Income/Share | -0.44 | 0.39 | -1.20 | -1.73 |
| EPS fr Continuing Ops. | -0.44 | 0.39 | -1.20 | -1.73 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.44 | 0.39 | -1.20 | -1.73 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.44 | 0.39 | -1.20 | -1.73 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.44 | 0.39 | -1.20 | -1.73 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ACAD
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserBerliner
- Contributor5 Stocks Under-$10 Setting ...
- Contributor10 Pharma Stocks Under $3
- Userazfar
- UserMy Portfolio
- UserNUKE PORTFOLIO
Latest ACAD Headlines from TheStreet
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- ACADIA Stock Gaps Down On Today's Open (ACAD) 04.26.12 | 09:04 am
- ACADIA Pharmaceuticals Inc. Stock Downgraded (ACAD) 04.11.12 | 05:04 am
- 8 Stocks Under $10 Moving Higher 03.20.12 | 12:03 pm
- ACADIA Stock Soars (ACAD) 03.13.12 | 03:03 pm
- 5 Stocks Under $5 Making Big Moves 03.13.12 | 02:03 pm
- ACADIA Stock Soars (ACAD) 01.18.12 | 04:01 pm
- 7 Stocks Under $10 Ripping Higher 12.20.11 | 02:12 pm
- Acadia Pharmaceuticals: Investing With No Safety Net 06.24.11 | 10:06 am
- 10 Pharma Stocks Under $3 06.16.11 | 01:06 pm
Press Releases for ACAD
- ACADIA Pharmaceuticals To Webcast Educational Program On Parkinson’s Disease Psychosis On May 22, 2012 - Business Wire 05.15.12 | 09:05 am
- ACADIA Pharmaceuticals Reports First Quarter 2012 Financial Results - Business Wire 05.08.12 | 04:05 pm
- ACADIA Pharmaceuticals To Present At The 19th Annual Future Leaders In The Biotech Industry Conference On April 20, 2012 - Business Wire 04.13.12 | 09:04 am
- ACADIA Pharmaceuticals To Present At The 11th Annual Needham Healthcare Conference On April 3, 2012 - Business Wire 03.28.12 | 09:03 am
- ACADIA Pharmaceuticals Awarded New Grant From The Michael J. Fox Foundation For Development Of Nurr1-RXR Selective Agonists To Treat Parkinson’s Disease - Business Wire 03.27.12 | 09:03 am
- ACADIA Pharmaceuticals Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2011 - Business Wire 03.06.12 | 04:03 pm
- ACADIA Pharmaceuticals Announces Extension Of Drug Discovery Collaboration With Allergan, Inc. - Business Wire 03.05.12 | 09:03 am
- ACADIA Pharmaceuticals To Present At Upcoming Investor Conferences - Business Wire 02.29.12 | 09:02 am
- ACADIA Pharmaceuticals To Announce Fourth Quarter And Full Year 2011 Financial Results On March 6, 2012 - Business Wire 02.28.12 | 09:02 am
- ACADIA Pharmaceuticals To Present At The 14th Annual BIO CEO & Investor Conference On February 13, 2012 - Business Wire 02.06.12 | 09:02 am
Partner Headlines for ACAD
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- 7 Healthcare Stocks Undervalued By Earnings Growth And Cash Flows - Seeking Alpha 02.03.12 | 07:02 pm
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.25.12 | 09:01 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 01.23.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.19.12 | 09:01 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 01.17.12 | 09:01 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.13.12 | 09:01 am
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
